Navigation Links
Effective Pain Relief For Patients Suffering From Multiple Sclerosis

Dronabinol, shows success reducing pain in patients with multiple sclerosis, according to a new study published . Dronabinol, also known as Marinol, has been used to soothe nausea and to stimulate appetite.// Researchers evaluated the effect of Dronabinol on pain in patients with multiple sclerosis.

24 patients with multiple sclerosis and central pain participated in the study . They were given up to 10 milligrams of dronabinol or a placebo for three weeks. Patients reported pain intensity was significantly lower and pain relief was higher during dronabinol treatment. The difference between treatments in pain reduction was about 21 percent. Pressure-evoked pain also tended to decrease, and patients reported better quality of life with dronabinol. The functional ability of the patients was not affected.

Adverse effects, dizziness being the most common, were more frequent with dronabinol than with placebo. Acute or chronic pain, including musculoskeletal pain, pain associated with spasms and central pain, occur in 30 percent to 80 percent of patients with multiple sclerosis. However, no patients stopped treatment because of adverse effects, which reportedly decreased after the first week of treatment.

Thus researchers conclude that dronabinol should be available for patients whose central pain from multiple sclerosis is not sufficiently treated with alternative drugs.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... CO (PRWEB) , ... April 24, 2017 , ... ... American Educational Research Association’s Outstanding Public Communication of Education Research Award. The award ... public, including education communities. It recognizes a scholar who has demonstrated the capacity ...
(Date:4/24/2017)... ... ... Pink , a national non-profit organization focusing on the prevention and early detection of breast ... proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay ... the Board and launched a national search to find a visionary new leader to grow ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health ... anywhere to track their cognitive health, and share results with their physicians. Members and ... on the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: